The Library

Multimodal functional imaging investigation before and after the onset of psychosis

Tools

Fusar-Poli, Paolo, Howes, Oliver (Oliver D.), Valli, Isabel, Allen, Paul, Broome, Matthew R., Grasby, Paul and McGuire, Philip. (2009) Multimodal functional imaging investigation before and after the onset of psychosis. International Journal of Neuropsychopharmacology, Vol.12 (No.4). pp. 579-581. ISSN 1461-1457

Preview

PDF
WRAP_Broome_2_S146114570800953Xa.pdf - Published Version - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (149Kb)

Official URL: http://dx.doi.org/10.1017/S146114570800953X

Abstract

Mr A. was a 20-yr-old white male with no medical
history of note. His GP, who was concerned about
his poor psychosocial functioning, referred him to a
specialist service offering advice and support for
young people at risk for psychosis.

Item Type:

Journal Article

Subjects:

R Medicine > RC Internal medicine

Divisions:

Faculty of Medicine > Warwick Medical School > Mental Health and Wellbeing
Faculty of Medicine > Warwick Medical School

Library of Congress Subject Headings (LCSH):

Schizophrenia -- Physiological aspects, Diagnostic imaging

Journal or Publication Title:

International Journal of Neuropsychopharmacology

Publisher:

Cambridge University Press

ISSN:

1461-1457

Official Date:

2009

Dates:

Date	Event
2009	Published

Volume:

Vol.12

Number:

No.4

Page Range:

pp. 579-581

Identification Number:

10.1017/S146114570800953X

Status:

Peer Reviewed

Access rights to Published version:

Open Access

References:

Cropley VL, Fujita M, Innis RB, Nathan PJ (2006). Molecular
imaging of the dopaminergic system and its association
with human cognitive function. Biological Psychiatry 59,
898–907.
Floresco SB, Magyar O (2006). Mesocortical dopamine
modulation of executive functions: beyond working
memory. Psychopharmacology 188, 567–585.
Fusar Poli P, Perez J, Broome M, Borgwardt S, Placentino A
(2007). Neurofunctional correlates of vulnerability to
psychosis: a systematic review and meta-analysis.
Neuroscience & Biobehavioral Reviews 31, 465–484.
Grunder G, Vernaleken I, Muller MJ, Davids E, Heydari N,
Buchholz HG (2003). Subchronic haloperidol
downregulates dopamine synthesis capacity in the brain of
schizophrenic patients in vivo. Neuropsychopharmacology
28, 787–794.
Howes OD, Montgomery AJ, Asselin MC, Murray RM,
Valli I, Grasby P (in press). Elevated striatal dopamine
function linked to prodromal signs of schizophrenia.
Archives of General Psychiatry.
McGlashan TH, Zipursky RB, Perkins D, Addington J,
Miller T (2006). Randomized, double-blind trial of
olanzapine versus placebo in patients prodromally
symptomatic for psychosis. American Journal of Psychiatry
163, 790–799.
McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S
(2002). Randomized controlled trial of interventions
designed to reduce the risk of progression to first-episode
psychosis in a clinical sample with subthreshold
symptoms. Archives of General Psychiatry 59, 921–928.
McGowan S, Lawrence AD, Sales T, Quested D, Grasby P
(2004). Presynaptic dopaminergic dysfunction in
schizophrenia: a positron emission tomographic
[18F]fluorodopa study. Archives of General Psychiatry 61,
134–142.
McGuire P, Howes OD, Stone J, Fusar-Poli P (2008).
Functional neuroimaging in schizophrenia: diagnosis
and drug discovery. Trends in Pharmacological Science
29, 91–98.
Tanaka S (2006). Dopaminergic control of working memory
and its relevance to schizophrenia: a circuit dynamics
perspective. Neuroscience 139, 153–171.
Vernaleken I, Kumakura Y, Cumming P, Buchholz HG,
Siessmeier T, Stoeter P (2006). Modulation of
[18F]fluorodopa (FDOPA) kinetics in the brain of healthy
volunteers after acute haloperidol challenge. Neuroimage
30, 1332–1339.
Weinhard K (1998). The Theory and Practice of 3D PET. In:
Bendriem B, Townsend DW(Eds), pp. 150–154. Dordrecht :
Kluwer Academic Publishers.
Yung A, Phillips L, McGorry P, Ward J, Donovan K (2002).
Comprehensive Assessment of At Risk Mental States
(CAARMS). Melbourne: PACE Clinic, Department of
Psychiatry, University of Melbourne.
Yung AR, Phillips LJ, Yuen HP, Francey SM,McFarlane CA
(2003). Psychosis prediction: 12-month follow up of a
high-risk (‘prodromal’) group. Schizophrenia Research
60, 21–32.